Zhang Ming-Rong, Suzuki Kazutoshi
Radiochemistry Section, Department of Molecular Probes, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba, Japan.
Curr Top Med Chem. 2007;7(18):1817-28. doi: 10.2174/156802607782507448.
Fluorine-18 ((18)F, beta(+); 96.7%, T(1/2)=109.8 min) is of considerable importance for developing positron emission tomography (PET) ligands for imaging receptor, enzyme, gene expression etc. in brain, tumor, myocardium and other regions or organs due to its optimal decay characteristics. To synthesize (18)F-labeled PET ligands, reliable labeling techniques inserting (18)F into a target molecule are necessary. [(18)F]Fluoroalkylation is a useful way of introducing (18)F into target molecules containing amino, phenol, thiophenol, and amide functional groups. Here, we review the preparation, reactivity and application of [(18)F]fluoroalkyl agents for the development of (18)F-labeled PET ligands in molecular imaging. [(18)F]Fluoroalkyl agents have been synthesized by reacting [(18)F]F(-) with the corresponding alkyl derivatives containing halogen and sulfonate as leaving groups. After the fluorination reaction, the radiolabeled products with relatively low boiling points were distilled from the reaction mixtures, sometimes added by Sep-Pak or gas chromatography separation. The [(18)F]fluoromethyl agents have high reactivity with nucleophilic substrates, but many [(18)F]fluoromethylated compounds are in vitro unstable. To increase the efficiency of [(18)F]fluoroethylation, [(18)F]FCH2CH2Br, the most frequently used [(18)F]fluoroethyl agent, was converted into [(18)F]FCH2CH2I or [(18)F]FCH2CH2OTf in situ. Most [(18)F]fluoromethylated ligands were found to be in vivo unstable due to defluorination. Deuterium substitution for the fluoromethyl group reduced defluorination to an extent. A number of [(18)F]fluoroethylated PET ligands have been developed for animal evaluation and clinical investigation.
氟 - 18((¹⁸)F,β⁺;96.7%,半衰期T₁/₂ = 109.8分钟)因其最佳的衰变特性,对于开发用于脑、肿瘤、心肌及其他区域或器官中受体、酶、基因表达等成像的正电子发射断层扫描(PET)配体具有相当重要的意义。为了合成¹⁸F标记的PET配体,需要可靠的将¹⁸F插入目标分子的标记技术。[¹⁸F]氟烷基化是将¹⁸F引入含有氨基、苯酚、苯硫酚和酰胺官能团的目标分子的一种有用方法。在此,我们综述了用于分子成像中¹⁸F标记PET配体开发的[¹⁸F]氟烷基试剂的制备、反应性及应用。[¹⁸F]氟烷基试剂是通过使[¹⁸F]F⁻与含有卤素和磺酸酯作为离去基团的相应烷基衍生物反应而合成的。氟化反应后,将沸点相对较低的放射性标记产物从反应混合物中蒸馏出来,有时还需通过Sep - Pak或气相色谱分离。[¹⁸F]氟甲基试剂与亲核底物具有高反应性,但许多[¹⁸F]氟甲基化化合物在体外不稳定。为了提高[¹⁸F]氟乙基化的效率,最常用的[¹⁸F]氟乙基试剂[¹⁸F]FCH₂CH₂Br被原位转化为[¹⁸F]FCH₂CH₂I或[¹⁸F]FCH₂CH₂OTf。大多数[¹⁸F]氟甲基化配体由于脱氟作用在体内不稳定。用氘取代氟甲基在一定程度上减少了脱氟。已经开发了许多[¹⁸F]氟乙基化PET配体用于动物评估和临床研究。